Dermatology
Skin clinical trials
Psoriasis, eczema, skin cancers, and other conditions of the skin and connective tissue. We’re tracking 5,032 recruiting studies in this area right now.
By phase
- Not applicable2,815
- Phase 2751
- Phase 1525
- Phase 3381
- Phase 1/Phase 2297
- Phase 4204
- Phase 2/Phase 359
Top conditions
- Breast Cancer1,197
- Melanoma174
- Metastatic Breast Cancer138
- Rheumatoid Arthritis131
- Atopic Dermatitis122
- Systemic Lupus Erythematosus121
- Breast Neoplasms111
- Triple Negative Breast Cancer110
- Colorectal Cancer95
- Ovarian Cancer91
- Psoriasis85
- Breast Carcinoma79
- Lung Cancer77
- Prostate Cancer70
- Rheumatoid Arthritis (RA)68
- Diabetic Foot Ulcer60
- Cancer58
- Systemic Lupus Erythematosus (SLE)52
Leading sponsors
- Fudan University64
- M.D. Anderson Cancer Center51
- Memorial Sloan Kettering Cancer Center49
- Novartis Pharmaceuticals48
- Mayo Clinic40
- AstraZeneca38
- Assistance Publique - Hôpitaux de Paris37
- National Cancer Institute (NCI)37
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University34
- Second Affiliated Hospital, Zhejiang University, School of Medicine30
Where studies are running
- California406
- Arizona150
- Alabama130
- Florida128
- New York110
- Texas106
- Maryland94
- Massachusetts86
- Pennsylvania72
- North Carolina68
Recruiting studies5,032 total
- NCT03454035RecruitingPhase 1
Combination of two study drugs for advanced pancreatic and other solid tumors
This trial tests two drugs, ulixertinib and palbociclib, taken together to see if they can shrink tumors in patients with advanced pancreatic cancer, melanoma, or other solid tumors. It may be an option for people who have already tried standard treatments.
Chapel Hill, North CarolinaAges 18–99 - NCT03414502RecruitingPhase 3
Predictors of Response to DMARDs in Rheumatoid Arthritis
This trial studies rheumatoid arthritis (RA) patients starting or adjusting DMARD medicines and looks for signs that predict who responds best. It may help doctors choose more effective treatment sooner.
Omaha, NebraskaAges 19 years+ - NCT03465150Recruiting
People with acne can join an acne patient study
This study creates a group (cohort) of patients treated for acne at a hospital to better understand acne care in real life. It may help improve future care by sharing what treatments people receive and how they do over time.
NantesAges Any age - NCT03417856Enrolling by invitation
Study skin and blood signs in ichthyosis
This study looks at “skin and blood biomarkers,” meaning measurable signs in the body, in people with ichthyosis to better understand the condition. It may help researchers find ways to track disease activity and evaluate future treatments.
Chicago, IllinoisAges 1–60 - NCT03326921RecruitingPhase 1
T cell treatment for leukemia after a bone marrow transplant
This early-phase trial tests an immune “T cell” therapy made to recognize a specific leukemia target. It is for people whose acute leukemia has come back (relapsed) or did not fully respond after receiving a donor stem cell transplant.
Seattle, WashingtonAges Up to 80 years - NCT03449238RecruitingPhase 1/Phase 2
Pembrolizumab with focused brain radiation for breast cancer brain spread
This trial studies whether pembrolizumab (an immune therapy medicine) plus stereotactic radiosurgery (focused radiation) can better control brain metastases from breast cancer. It may help shrink or slow growth of multiple brain spots with minimal treatment to surrounding tissue.
New York, New YorkAges 19–90 - NCT03337932Recruiting
Shorter doxycycline course for multiple early Lyme skin rashes
This study looks at how long to take doxycycline for people who have multiple early Lyme disease skin rashes. It may help find the shortest effective treatment duration while keeping side effects low.
LjubljanaAges 18 years+ - NCT03340129RecruitingPhase 2
Nivolumab plus focused brain radiation for melanoma spread
This trial studies whether giving the immunotherapy drug nivolumab together with targeted brain radiation (not whole-brain radiation) helps people with melanoma that has spread to the brain. It aims to improve brain control while keeping side effects manageable.
Sydney, New South WalesAges 18–120 - NCT03503240Enrolling by invitation
Skin cancer surgery study about satisfaction, scars, and quality of life
This study asks people who had skin cancer surgery about how they feel about their appearance, their scar healing, and their quality of life. It may help doctors understand what outcomes matter most to patients after skin cancer treatment.
Sacramento, CaliforniaAges 21 years+ - NCT03429426Enrolling by invitation
Tracking joint bone damage in rheumatoid arthritis with scans
This study uses high-resolution scans and regular X-rays to see how bone erosions (bone wear) progress in people with rheumatoid arthritis over time. It may help researchers better understand disease changes and how to measure them.
AarhusAges 18 years+ - NCT03254667Enrolling by invitation
Track outcomes in adults with moderate-to-severe psoriasis
This study keeps track of how people with moderate-to-severe psoriasis do over time while using Siliq or other approved treatments. It may help researchers understand how treatments compare in real life.
Bridgewater, New JerseyAges 18–99 - NCT03275311Recruiting
Care approach changes for metastatic breast cancer
This trial looks at how treatment care for metastatic breast cancer has evolved over time. You may be eligible if you are an adult receiving active cancer treatment in a comprehensive cancer center in France.
AngersAges 18 years+ - NCT03146676Recruiting
OSU Dermatology Biorepository for donated skin tissue and data
This study collects and stores skin samples and related health information from people seen in OSU Dermatology clinics. It helps researchers better understand skin conditions and may lead to new treatments in the future.
Columbus, OhioAges Any age - NCT03124212Recruiting
Genetic testing guidance for inherited breast, ovarian, or colon cancer risk
This study helps people in Switzerland who already have a known inherited cancer gene change understand what it means for them and their family. It focuses on people with specific known mutations related to hereditary breast/ovarian cancer and Lynch syndrome.
Fribourg, Canton of FribourgAges 18 years+ - NCT03192267Recruiting
Study of lung changes in early rheumatoid arthritis
This study looks at lung health in people with early rheumatoid arthritis (RA). It may help doctors understand how RA affects the lungs soon after diagnosis and guide better care.
Omaha, NebraskaAges 19–90 - NCT03155854Recruiting
Surgery to prevent scarring in trigger finger
This study looks at whether doing a limited surgery in advance can improve outcomes and reduce scarring for people with trigger finger who also have a specific palm cord condition. It may help you heal better if you’ve already tried non-surgical treatment or chose surgery.
Rochester, MinnesotaAges 18 years+ - NCT03087253Recruiting
Study of what causes and affects lipodystrophy
This study observes people with lipodystrophy to better understand how the condition develops and affects the body over time. It may help researchers learn who is most affected and guide future treatments.
Bethesda, MarylandAges Any age - NCT03125655Recruiting
Study of gene regulation in psoriasis skin
This study looks at how inflammation-related genes behave in people with psoriasis. It may help researchers understand why psoriasis flares and how it could be better treated.
Birmingham, AlabamaAges 19–99 - NCT03022773Enrolling by invitation
Eye exam study measuring macular pigment in specific eye disease
This study measures a pigment in the eye and also looks at other body tissues in people who have a specific inherited eye condition called adult vitelliform dystrophy. It may help researchers better understand the disease and how it can be confused with early age-related macular degeneration.
Salt Lake City, UtahAges 7 years+ - NCT03050268Recruiting
Study of childhood cancer risk in families
This study looks at inherited (family) risk for childhood cancers, including families with early cancers or known cancer risk conditions. It may help researchers understand why some children get cancer and improve future risk detection and care.
Memphis, TennesseeAges Any age - NCT03093909RecruitingPhase 1
Breathing treatment with gemcitabine for lung cancer spread
This early-stage trial studies an inhaled (aerosol) form of gemcitabine to treat solid tumors that have spread to the lungs. It aims to see whether this lung-focused treatment is safe and how well it might work when standard curative options are not available.
Houston, TexasAges 12–50 - NCT03113643RecruitingPhase 1
SL-401 with standard drugs for hard-to-treat blood cancers
This Phase 1 study tests SL-401, given with azacitidine and sometimes venetoclax, to treat acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or blastic plasmacytoid dendritic cell neoplasm (BPDCN). It aims to find a safe dose and see whether the combination can improve blood cancer control.
Duarte, CaliforniaAges 18 years+ - NCT02338167Recruiting
Study for pregnant women with breast cancer
This study is for adults with breast cancer who are pregnant and are either newly diagnosed (early) or have locally advanced or metastatic disease. It aims to better understand how breast cancer treatment should be managed during pregnancy.
Böblingen, Baden-WurttembergAges 18–99 - NCT01503190Recruiting
Study of how breast cancer affects the immune system
This study looks at how the immune system changes in people with breast cancer, using patient tissue samples. It may help researchers understand immune responses in young women and guide future cancer treatments.
Aurora, ColoradoAges 18 years+
Common questions
- How many skin clinical trials are recruiting?
- Clin2 is tracking 5,032 recruiting dermatology studies from the U.S. registry right now, out of 7,856 we cover in this area in total.
- What does “Skin” cover here?
- Psoriasis, eczema, skin cancers, and other conditions of the skin and connective tissue. We group each study into skin based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a skin trial near me?
- Use the search to filter skin studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.